MedSmart Group Inc.

As of September 30, 2014, MedSmart Group Inc. carries a market capitalization of 673,446.50, placing it among publicly traded companies globally. Its enterprise value stands at 1.86M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2014, MedSmart Group Inc. has 1.35M shares outstanding.

As of September 30, 2014, MedSmart Group Inc. trades at a trailing price-to-earnings ratio of 3.32. The price-to-sales ratio is 0.50, and the price-to-book ratio stands at -0.23.

As of September 30, 2014, MedSmart Group Inc. trades at an EV/EBITDA multiple of 9.36 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.56 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 10.94 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. MedSmart Group Inc. trades at an EV/FCF ratio of 1.51, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 1.86M versus a market cap of 673,446.50, with the gap driven by net debt and cash on the balance sheet.

As of September 30, 2014, MedSmart Group Inc. maintains a current ratio of 0.03, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -38.67, indicating conservative leverage, while an interest coverage ratio of 3.28 demonstrates adequate ability to service its debt obligations.

These figures cover the twelve months ended September 30, 2014. Return on assets (ROA) stands at 130.44, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is negative at -9.90, pointing to unprofitable operations over the period. The company generates approximately 181,702.75 in revenue per employee across its workforce of 4.00, a quick read on workforce productivity versus industry peers.

As of the close on October 13, 2026, MedSmart Group Inc.'s stock has gained approximately 2000.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.39.

Over the twelve months ended September 30, 2014, MedSmart Group Inc. generated 726,811.00 in revenue and converted that into 109,533.00 in net income, yielding earnings per share of 0.08. EBITDA reached 198,827.00, while operating income came in at 170,119.00.

As of September 30, 2014, MedSmart Group Inc. holds - - in cash and equivalents against 1.12M in total debt, resulting in a net debt position of 1.12M. Total book value stands at -2.97M, with working capital of -2.91M providing operational flexibility.

MedSmart Group Inc. produced 1.17M in operating cash flow over the twelve months ended September 30, 2014. After subtracting - - in capital expenditures, free cash flow totaled 1.17M - equivalent to 1.61 per share.

Over the twelve months ended September 30, 2014, MedSmart Group Inc. posted a gross margin of 53.08, reflecting its pricing power and cost economics. The operating margin of 23.41 and net profit margin of 15.07 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2014. Free cash flow yield stands at 174.97, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 282.23, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to MedSmart Group Inc. shareholders.

MedSmart Group Inc.'s most recent stock split took place on November 23, 2020.

As of September 30, 2014, MedSmart Group Inc. has an Altman Z-Score of -312.50, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.